GLP-1 users often prefer smaller portions of desserts that feel satisfying without causing digestive discomfort
10,11 Nevertheless, research exploring the relationship between flavonoids, gut hormones, and diabetes remains limited
Combining dose tapering with intensive behavioral support (structured meal planning, accountability coaching, consistent resistance training) helps preserve 20 to 40 percent of weight loss even after treatment ends
AASLD The Liver Meeting Digital Experience, November 13-16, 2020
There is no one size fits all answer, but here are the clinical criteria we often consider at Advanced Scripts: Semaglutide may be the right starting point if: You are new to GLP-1 therapy: It is a well-established, effective first-line treatment